Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email
Dr. Paul Okano,

Paul Okano, Ph.D.

Program Director
Division of Cancer Biology (DCB)
DNA and Chromosome Aberrations Research Branch
240-276-6250
|
okanop@mail.nih.gov

Dr. Paul Okano has expertise in epigenetics, mutagenesis, DNA repair, and DNA damage. He manages a portfolio of grants focusing on the role of epigenetic modifications to DNA, RNA and histones, mechanisms of lesion-induced DNA mutagenesis, DNA lesions induced by chemicals, oxidants, and UV, DNA repair mechanisms, and the role of translesion and mutant polymerases in cancer.

Along with his work in DCB, Dr. Okano is also involved in the eRA Technical User Group and the trans-NIH Mitochondrial Diseases Working Group. 

 

Background

Prior to his work as a DCB program director, Dr. Okano was a staff fellow at NCI where he studied chemical carcinogenesis and carcinogen metabolism. 

 

Education

  • Ph.D., Molecular Biology, University of California, Los Angeles  
  • Updated:
Email